answering body |
Department of Health and Social Care |
|
|
question text |
To ask the Secretary of State for Health and Social Care, what assessment his Department
has made of the potential merits of using models that de-link the cost of research
and development from the price of the final product and the volume of sales, as set
out in the 2016 UN Political Declaration of the High-Level Meeting of the General
Assembly on antimicrobial resistance, to ensure that new diagnostics, medicines and
tools created are accessible and affordable.
|
|